Renaissance Technologies’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-414,425
| Closed | -$132K | – | 3684 |
|
|
2018
Q1 | $132K | Buy |
+414,425
| New | +$132K | ﹤0.01% | 3234 |
|
|
2016
Q1 | – | Sell |
-33,625
| Closed | -$1.25M | – | 3643 |
|
|
2015
Q4 | $1.25M | Buy |
33,625
+12,500
| +59% | +$464K | ﹤0.01% | 2360 |
|
|
2015
Q3 | $1.03M | Buy |
+21,125
| New | +$1.03M | ﹤0.01% | 2362 |
|
|
2015
Q2 | – | Sell |
-2,288
| Closed | -$82K | – | 3490 |
|
|
2015
Q1 | $82K | Buy |
+2,288
| New | +$82K | ﹤0.01% | 3032 |
|
|
2014
Q4 | – | Sell |
-3,338
| Closed | -$51K | – | 3229 |
|
|
2014
Q3 | $51K | Sell |
3,338
-12,274
| -79% | -$188K | ﹤0.01% | 2711 |
|
|
2014
Q2 | $423K | Buy |
15,612
+3,437
| +28% | +$93.1K | ﹤0.01% | 2382 |
|
|
2014
Q1 | $326K | Buy |
12,175
+3,837
| +46% | +$103K | ﹤0.01% | 2496 |
|
|
2013
Q4 | $205K | Buy |
8,338
+2,332
| +39% | +$57.3K | ﹤0.01% | 2610 |
|
|
2013
Q3 | $193K | Buy |
6,006
+1,263
| +27% | +$40.6K | ﹤0.01% | 2586 |
|
|
2013
Q2 | $141K | Buy |
+4,743
| New | +$141K | ﹤0.01% | 2576 |
|